algorithm Sep 2, 2022 Owkin Digital Pathology Algorithms for Colorectal, Breast Cancer Receive CE Mark Apr 7, 2022 Pangea Biomed Builds on RNA-Based Drug Matching to Expand Precision Oncology Opportunities Premium Aug 12, 2021 Australian Researchers Develop Tool to Support Physicians' Precision Oncology Treatment Decisions Premium Jul 28, 2021 PathAI Leveraging Acquisition, $165M Financing to Expand Dx Business Premium May 28, 2021 Tool Detects Pediatric Bone Tumors From Liquid Biopsies Based on Epigenetic Profiles May 21, 2021 Macrophage Subpopulation May Predict Kidney Cancer Recurrence, Serve as Drug Target Apr 30, 2021 Transcriptomic Algorithm Shows Ability to Predict Progression-Free Survival in Cancer Patients Premium Mar 11, 2021 Sequencing-Based Clinical Trial Matching Yields High False-Positive Rates Premium Mar 5, 2021 Allarity Therapeutics Begins European Study of Ixempra for Biomarker-Selected Breast Cancer Patients Mar 2, 2021 PreludeDx DCIS Breast Cancer Test Helps Determine Radiation Therapy Benefits, Reduce Overtreatment Premium Sep 25, 2020 Relay Therapeutics Uses Protein Motion Simulation to Develop Highly Selective Precision Cancer Drugs Premium Aug 4, 2020 BostonGene Partners With Dana-Farber's Weinstock Lab on T-Cell Lymphoma Biomarker Research Apr 14, 2020 Second Chance for Dovitinib: Oncology Venture to Seek Approval for Once-Failed TKI in Kidney Cancer Premium Jan 14, 2020 Immunotherapy Response Prediction Improves With TMB Correction, Other Markers Premium May 22, 2019 PreludeDx Receives New York State Approval for DCIS Test Apr 18, 2019 Harvard Team Advancing Algorithmic Signature to Improve PARP Inhibitor Patient Selection Premium Mar 20, 2019 Canopy Biosciences Aims to Improve Rare Variant Detection With Error-Correction Sequencing Service Premium Breaking News In Brief This Week: Gilead Sciences, Arcus Biosciences, Verismo Therapeutics, Caris Life Sciences Pyxis Oncology Gets FDA Permission to Start Phase I Trials of Anti-EDB Drug, Immunotherapy FDA Approves Rigel Pharmaceuticals' Rezlidhia for IDH1-Mutant AML Sofie Biosciences to Begin Trial of Fluorine-Labeled PET Diagnostic Imaging Agent for GI Cancers Study Unearths Features Found in Long-Term Survivors of Advanced Ovarian Cancer Carrick Therapeutics Receives $35M Investment From Pfizer; Raises $25M in Series C Funding Round
